openPR Logo
Press release

EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 2023

01-06-2021 08:29 AM CET | Science & Education

Press release from: Orion Market Research

EPO biomarkers Market Trends 2018 | Segmentation, Outlook,

Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Erythropoietin alfa is used to treat anemia and cancer cells and it increases the count of red blood cells in the body. Erythropoietin is mostly administered as an alternative to iron supplements. Moreover, the erythropoietin biomarkers are used to treat end-stage renal diseases (ESRD), and anemia induced from multiple myeloma, cancer, and AIDS associated anemia.

Request a Free Sample of our EPO biomarkers Market: https://www.omrglobal.com/request-sample/epo-biomarkers-market

Major factors contributing to the growth of the global EPO biomarkers market include increasing sedentary lifestyle and faulty dietary habits has increased the prevalence of cancers and chronic kidney diseases in the emerged economies. Moreover, the increasing incidence of end-stage renal disorders and hematological diseases is further increasing the demand for EPO biomarkers. The patent expiration of EPO biomarkers is significantly increasing the introduction of novel EPO biomarkers in the market. However, the lack of quality control testing laboratories in emerging economies such as India and China is a major factor hindering the growth of the market. Improper price capping regulations across the globe is another factor that is significantly responsible in hampering the growth of the global EPO biomarkers market. However, the favorable healthcare regulations in emerged economies such as the U.S. and rising prevalence of chronic diseases such as cancer is expected to fuel the market growth in the near future.

The EPO Biomarkers Market can be segmented on the basis of biomarker type, applications, and end users. Based on biomarker type, the market is segmented into erythropoietin alfa, erythropoietin beta, erythropoietin zeta, erythropoietin theta, recombinant human erythropoietin, and darbepoietin alfa. Based on application, the market is bifurcated into end-stage renal disorder, cancers, rheumatoid arthritis, AIDS, myelodysplastic syndrome, neurology, hematology, and others (anaemia of chronic inflammatory syndromes). Based on end users, the market is segmented into diagnostic centers, ambulatory care and surgical centers, and hospitals. Among biomarker type, the erythropoietin alfa segment holds a major share in the global EPO biomarkers market. This is owing to increasing adoption in the treatment of chronic renal disorders and cancer.
The global EPO biomarkers market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global EPO biomarkers market, followed by Europe. This is mainly owing to the developed healthcare infrastructure in the region. Moreover, the systematic initiatives taken by the government in the research and development activities is one of the major factors contributing in the growth of the EPO biomarkers market in the region. Asia Pacific is projected to exhibit the fastest growth in the global market over the forecast period. Some of the major factors that are significantly contributing in the growth of the market in Asia Pacific are low cost of treatment therapy and increasing incidence rate of hematological diseases in the region, especially in India, China, Pakistan, and Bangladesh.

A full Report of EPO biomarkers Market is Available at: https://www.omrglobal.com/industry-reports/epo-biomarkers-market

EPO biomarkers MARKET SEGMENTATION

BY BIOMARKERTYPE

ERYTHROPOIETINALFA
ERYTHROPOIETINBETA
ERYTHROPOIETINZETA
ERYTHROPOIETINTHETA
RECOMBINANTHUMANERYTHROPOIETIN
DARBEPOIETINALFA

BYAPPLICATIONS

END-STAGERENALDISORDER
CANCERS
RHEUMATOIDARTHRITIS
AIDS
MYELODYSPLASTICSYNDROME
NEUROLOGY
HEMATOLOGY
OTHERS (ANAEMIA OF CHRONIC INFLAMMATORY SYNDROMES)
BYENDUSERS
DIAGNOSTICCENTERS
AMBULATORYCAREANDSURGICALCENTERS
HOSPITALS

COMPETITIVELANDSCAPE

KEYMARKETSTRATEGIES
KEYCOMPANYANALYSIS
REGIONALANALYSIS

NORTHAMERICAN
UNITEDSTATES
CANADA
EUROPE
U.K
GERMANY
ITALY
SPAIN
FRANCE
ROE
ASIAPACIFIC
INDIA
CHINA
JAPAN
ROAPAC
REST OF THE WORLD
COMPANYPROFILES

3SBIOGROUP
AGILENTTECHNOLOGIES, INC.
AMGENINC.
BIOAGILYTIXLABS
BIOCON
BIO-RADLABORATORIES, INC.
EVETECHNOLOGIES
F. HOFFMANN-LAROCHELTD
GALENICAAG
GENSCRIPT
GLAXOSMITHKLINEPLC.
INTASPHARMACEUTICALSLTD.
JOHNSON&JOHNSONSERVICES, INC.
KYOWAHAKKOKIRINCO., LTD.
LGLIFESCIENCESPVTLTD
MERCKKGAA
MYRIADRBM
NOVARTISAG
PACIFICBIOMARKERS
PFIZERINC.
SANDOZINTERNATIONALGMBH
SHANDONGKEXING
SIEMENSAG
THERMO FISHER SCIENTIFIC

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/epo-biomarkers-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based service

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 2023 here

News-ID: 2221188 • Views: 144

More Releases from Orion Market Research

Asia Pacific Calcium Carbonate Market 2020 Growth, COVID Impact, Trends Analysis …
Asia-Pacific calcium carbonate market is estimated to grow at a CAGR of 4.1% during the forecast period. Significant growth in end-user industries such as plastics, paper, and paints and coatings industry is primarily driving the demand for calcium carbonate in the region. China holds the largest share in the plastics manufacturing globally, which is followed by Europe and NAFTA. Plastics manufacturing has also witnessed significant growth in India. For instance,
US Home Gym Equipment Market 2020 Growth, COVID Impact, Trends Analysis Report 2 …
The US home gym equipment market is estimated to exhibit a sturdy CAGR during the forecast period (2020-2026). The sales of home gym equipment have witnessed a recording-breaking surge in the initial months of the COVID-19 pandemic as most of the fitness centers and gyms were closed in compliance with the lockdown regulations. Even before the arrival of COVID-19, the country experienced a surge in the fitness conscious individuals as
Spain Electric Vehicle Charger Market Trends 2019 | Segmentation, Outlook, Indus …
Spain electric vehicle charger market is anticipated to grow at a CAGR of over 20% during the forecast period, 2019-2025. In 2019, the government of Spain announced a target of 100% Zero Emission Vehicle (ZEVs) by 2040. Government subsidies in order to motivate the electric vehicle market are one of the major factors for the growth of the market in the country. The country introduced first subsidies on electric vehicle
European Calcium Carbonate Market Growth, Size, Share and Forecast 2020-2026
European calcium carbonate market is estimated to grow at a CAGR of 2.9% during the forecast period. As per the Confederation of European Paper Industries (CEPI), the pulp and paper industry in Europe generated a turnover of nearly $101 billion in 2019. The production capacity of paper and board in Europe increased from 101.2 million tons in 2018 to 101.5 million tons in 2019. Calcium carbonate is often utilized in

All 5 Releases


More Releases for EPO

Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023 According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,
Quercetin Market Global Forecast 2018 | Studied By Monteloeder, EPO S.r.l., King …
UpMarketResearch published an exclusive report on “Quercetin market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 112 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Quercetin market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa.
Global Erythropoietin (EPO) Market 2017 - Johnson & Johnson, Roche, Kyowa Hakko …
Global Erythropoietin (EPO) market Report offers decisive insights into the overall Erythropoietin (EPO) industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Erythropoietin (EPO) industry segments based on the type of applications, type of product Components and services, and different geographical regions. Erythropoietin, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports. Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlo …
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle
Global Erythropoietin (EPO) Market With Focus On Asia: Industry Analysis & Outlo …
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle